BioXcel Therapeutics, Inc. (BTAI) › Shares OutstandingBioXcel Therapeutics, Inc. (BTAI) — Shares OutstandingAnnual figures by period end, from SEC filings.2017-12-31: 9.91M2018-12-31: 15.66M2019-12-31: 18.09M2020-12-31: 24.42M2021-12-31: 27.98M2022-12-31: 28.15M2023-12-31: 1.87M2024-12-31: 3.10M2025-12-31: 22.33M22.33M2017-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-3122.33M+619.8%2026-03-27Balance as of period end2024-12-313.10M+65.8%2026-03-27Balance as of period end2023-12-311.87M-93.4%2025-03-28Balance as of period end2022-12-3128.15M+0.6%2024-03-22Balance as of period end2021-12-3127.98M+14.6%2023-03-16Balance as of period end2020-12-3124.42M+35.0%2022-03-11Balance as of period end2019-12-3118.09M+15.5%2021-03-12Balance as of period end2018-12-3115.66M+58.1%2020-03-09Balance as of period end2017-12-319.91M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)